image
Evolus, Inc. EOLS
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 10.04
-0.612 %
$ 647 M
Market Cap
-10.94
P/E
Price Target Average
139.04%
Revenue Forecast Estimate
32.53%
EBIT Estimate
--80.97%
Net Income Estimate
53.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Evolus, Inc.
image
Wall Street analysts predict an average 1-year price target for EOLS of $24 , with forecasts ranging from a low of $20 to a high of $27 .
EOLS Lowest Price Target Wall Street Target
20 USD 99.20%
EOLS Average Price Target Wall Street Target
24 USD 139.04%
EOLS Highest Price Target Wall Street Target
27 USD 168.92%
Price
Max Price Target
Min Price Target
Average Price Target
282826262424222220201818161614141212101088Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart EOLS

image
$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart EOLS

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart EOLS

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029